Anebulo Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ANEB and other ETFs, options, and stocks.About ANEB
Anebulo Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the provision of pharmaceutical services. Its product candidate, Selonabant, is a small molecule antagonist of cannabinoid binding receptor type-1.
CEORichard Anthony Cunningham
CEORichard Anthony Cunningham
Employees3
Employees3
HeadquartersLakeway, Texas
HeadquartersLakeway, Texas
Founded2020
Founded2020
Employees3
Employees3
ANEB Key Statistics
Market cap92.85M
Market cap92.85M
Price-Earnings ratio-9.73
Price-Earnings ratio-9.73
Dividend yield—
Dividend yield—
Average volume11.40K
Average volume11.40K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$3.42
52 Week high$3.42
52 Week low$0.8001
52 Week low$0.8001
Stock Snapshot
The current Anebulo Pharmaceuticals(ANEB) stock price is $2.26, with a market capitalization of 92.85M. The stock trades at a price-to-earnings (P/E) ratio of -9.73.
On 2025-12-15, Anebulo Pharmaceuticals(ANEB) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for Anebulo Pharmaceuticals(ANEB) stock has reached 0, versus its average volume of 11.4K.
Over the past 52 weeks, Anebulo Pharmaceuticals(ANEB) stock has traded between a high of $3.42 and a low of $0.80.
Over the past 52 weeks, Anebulo Pharmaceuticals(ANEB) stock has traded between a high of $3.42 and a low of $0.80.
People also own
Based on the portfolios of people who own ANEB. This list is generated using Robinhood data, and it’s not a recommendation.